Jazz Pharmaceuticals plc — Director's Dealing 2012

Feb 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2012-01-30

Reporting Person: COZADD BRUCE C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-30	Ordinary Shares	J	255	—	Acquired	547066	Direct

Footnotes

F1: Pro rata distribution for no consideration from Versant Affiliates Fund II-A, L.P. (the "Partnership"), of which the Reporting Person is a limited partner with no voting or investment control of the Partnership or its general partner.

F2: The ordinary shares of the Issuer being distributed by the Partnership were received by the Partnership on January 18, 2012 in connection with the closing of the merger pursuant to the Agreement and Plan of Merger and Reorganization by and among the Issuer, Jaguar Merger Sub Inc., Jazz Pharmaceuticals, Inc. and Seamus Mulligan, solely in his capacity as indemnitors' representative, and were acquired in exchange for shares of common stock of Jazz Pharmaceuticals, Inc. which were owned by the Partnership since April 30, 2003, August 29, 2003 and January 14, 2004.